Outcomes of ED chest pain visits: the prognostic value of negative but measurable high-sensitivity cardiac troponin (hs-cTn) levels

被引:0
|
作者
Greenberg, Sharon A. [1 ]
Cohen, Neta [2 ]
Shopen, Noa [1 ]
Mordechai, Reut Aviv [1 ]
Zeltser, David [1 ]
Werthein, Julieta [1 ]
机构
[1] Tel Aviv Univ, Dana Dwek Childrens Hosp, Tel Aviv Sourasky Med Ctr, Emergency Med Dept,Fac Med, 6 Weizmann St, IL-6423906 Tel Aviv, Israel
[2] Tel Aviv Univ, Dana Dwek Childrens Hosp, Tel Aviv Sourasky Med Ctr, Fac Med,Pediat Emergency Med Dept, Tel Aviv, Israel
来源
BMC EMERGENCY MEDICINE | 2024年 / 24卷 / 01期
关键词
ED discharge; Chest pain; Troponin; Outcomes after discharge; ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; ST-SEGMENT ELEVATION; ADMISSION RATES; PERSISTENT; MANAGEMENT;
D O I
10.1186/s12873-024-01128-1
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BackgroundChest pain is a common condition in the emergency department (ED). High-sensitivity cardiac troponin (hs-cTn) assays are crucial for diagnosing acute coronary syndrome, but the implications of "negative but measurable" hs-cTn levels are not well understood. This study assesses the outcomes of patients with acute chest pain discharged from the ED based on their hs-cTn levels. MethodsThis retrospective cohort study analyzed medical records of patients aged 18 and older presenting with chest pain to the Tel Aviv Sourasky Medical Center ED from 2017 to 2022. We compared patients with negative but measurable hs-cTn levels (3-50 ng/L) to those with very low hs-cTn levels (< 3 ng/L). Primary outcomes included 90- days coronary angiogram (CAG), and secondary outcomes were 7- days ED revisits, 14-days hospital admissions, and 30- days mortality. ResultsOf 32,162 eligible patients, 23,297 had hs-cTn levels <= 50 ng/L. Patients with negative but measurable hs-cTn levels had higher rates of 90-days CAG (1.8% vs. 0.5%, p < 0.001), 7-day ED revisits (5.2% vs. 3.3%, p < 0.001), 14-day hospital admissions (3.1% vs. 0.9%, p < 0.001), and 30-day mortality (0.3% vs. 0.01%, p < 0.001) compared to those with very low hs-cTn levels. Independent predictors for 90 days CAG included age >= 57 years, male sex, and hs-cTn >= 3.5 ng/L. ConclusionsNegative but measurable hs-cTn levels are linked to worse outcomes than very low hs-cTn levels in discharged ED patients. Closer follow-up and further cardiac evaluation may be warranted for these patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Risk stratification in patients with acute chest pain with normal high-sensitivity cardiac troponin levels and need for downstream testing
    Smulders, M. W.
    Bekkers, S. C. A. M.
    Liefhebber, A.
    Vervuurt, J.
    Van Dieijen-Visser, M. P.
    Mingels, A. M. A.
    Brunner-La Rocca, H. P.
    Dagnelie, P. C.
    Crijns, H. J. G. M.
    Kietselaer, B. L. J. H.
    EUROPEAN HEART JOURNAL, 2015, 36 : 760 - 760
  • [22] Prognostic Value of High-Sensitivity Cardiac Troponin I in Patients with Chronic Kidney Disease
    Hashimoto, Tousei
    Ishii, Junichi
    Okumura, Masanori
    Naruse, Hiroyuki
    Mori, Yoshihisa
    Matsui, Shigeru
    Hasegawa, Midori
    Nomura, Masanori
    Yuzawa, Yukio
    Ozaki, Yukio
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (09) : S164 - S164
  • [23] A Practical Approach for the Use of High-Sensitivity Cardiac Troponin Assays in the Evaluation of Patients With Chest Pain
    Azar, Rabih R.
    Sarkis, Antoine
    Giannitsis, Evangelos
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 139 : 1 - 7
  • [24] Survival and resource utilization in patients with chest pain evaluated with cardiac troponin T compared with high-sensitivity cardiac troponin T
    Bandstein, Nadia
    Wikman, Anna
    Ljung, Rickard
    Holzmann, Martin J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 245 : 43 - 48
  • [25] Acute chest pain in the high-sensitivity cardiac troponin era: A changing role for noninvasive imaging?
    Smulders, Martijn W.
    Kietselaer, Bas L. J. H.
    Schalla, Simon
    Bucerius, Jan
    Jaarsma, Caroline
    van Dieijen-Visser, Marja P.
    Mingels, Alma M. A.
    Brunner-La Rocca, Hans-Peter
    Post, Mark
    Das, Marco
    Crijns, Harry J. G. M.
    Wildberger, Joachim E.
    Bekkers, Sebastiaan C. A. M.
    AMERICAN HEART JOURNAL, 2016, 177 : 102 - 111
  • [26] The role of elevated high-sensitivity cardiac troponin on outcomes following severe blunt chest trauma
    Keskpaik, Triinu
    Starkopf, Joel
    Kirsimagi, Ulle
    Mihnovits, Vladislav
    Lomp, Andrus
    Raamat, Eeva-Maarja
    Saar, Sten
    Talving, Peep
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2020, 51 (05): : 1177 - 1182
  • [27] Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease
    Biener, Moritz
    Giannitsis, Evangelos
    Lamerz, Judith
    Mueller-Hennessen, Matthias
    Vafaie, Mehrshad
    Katus, Hugo A.
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2016, 5 (06) : 409 - 418
  • [28] Risk stratification and role for additional diagnostic testing in patients with acute chest pain and normal high-sensitivity cardiac troponin levels
    Smulders, Martijn W.
    Bekkers, Sebastiaan C. A. M.
    van Cauteren, Yvonne J. M.
    Liefhebber, Anna
    Vermeer, Jasper R.
    Vervuurt, Juliette
    van Dieijen-Visser, Marja P.
    Mingels, Alma M. A.
    Rocca, Hans-Peter Brunner-La
    Dagnelie, Pieter C.
    Wildberger, Joachim E.
    Crijns, Harry J. G. M.
    Kietselaer, Bas L. J. H.
    PLOS ONE, 2018, 13 (09):
  • [29] Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T
    Bholasingh, R
    Cornel, JH
    Kamp, O
    van Straalen, JP
    Sanders, GT
    Tijssen, JGP
    Umans, VAWM
    Visser, CA
    de Winter, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (04) : 596 - 602
  • [30] Myocardial Scintigraphy For Emergency Care In Patients Presenting With Acute Chest Pain And Negative High-Sensitivity Troponin
    Lattuada, F.
    Gotuzzo, I.
    Ferro, P.
    Boni, R.
    Vai, P.
    Slart, R. H. J. A.
    Erba, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S619 - S619